Sheng Wang Tu
Director/Board Member at Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Profile
Sheng Wang Tu currently works at Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd., as Director.
Sheng Wang Tu active positions
| Companies | Position | Start |
|---|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
 Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Stock Market
- Insiders
- Sheng Wang Tu
